Showing 761-770 of 23022 results for "".
Using a Biologic in a Patient with Atopic Dermatitis and HSV Keratitis
https://reachmd.com/programs/cme/using-a-biologic-in-a-patient-with-atopic-dermatitis-and-hsv-keratitis/11241/Since dupilumab can cause conjunictivitis, is it safe to use in our atopic dermatitis patients with HSV keratitis who have exhausted other options?Options for an Infant with Atopic Dermatitis
https://reachmd.com/programs/cme/options-for-an-infant-with-ad/11242/A mutlidisciplinary panel discusses treatment options for an infant with severe, refractory atopic dermatitis.Insulin Pump Practices
https://reachmd.com/programs/diabetes-discourse/insulin-pump-practices/6462/Insulin pump practice studies reveal new approaches in the management of diabetes, including carb-counting, carb boluses, hypoglycemia and transdermal insulin drug delivery. What are actual pump practices that lead to improved control? Join host Dr. Steven Edelman and his guest, John Walsh, PA, andStuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
https://reachmd.com/programs/cme/stuck-on-antihistamines-for-managing-patients-with-ckd-ap-time-to-reconsider/37607/Apply clinical practice guideline recommendations in managing patients with chronic kidney disease-associated pruritus (CKD-aP).Targeting CKD-aP at the Source: Key Mechanisms and Treatments
https://reachmd.com/programs/cme/targeting-ckd-ap-at-the-source-key-mechanisms-and-treatments/37606/Explore CKD-associated pruritus mechanisms, clinical impact, and evidence-based treatments, including kappa-opioid receptor agonists.Progress in Breast Cancer Care: Translating SABCS Data Into Practice
https://reachmd.com/programs/cme/progress-in-breast-cancer-care-translating-sabcs-data-into-practice/48989/Learn to integrate the latest data on ADCs in breast cancer into clinical practice, expand treatment options, and apply emerging evidence in real-world care.HER2 in Bladder Cancer: Breaking Through the Molecular Frontier
https://reachmd.com/programs/cme/her2-in-bladder-cancer-breaking-through-the-molecular-frontier/35561/Explore HER2 as a therapeutic target in bladder cancer, from molecular testing to HER2-directed treatment strategies and multidisciplinary AE management.Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
https://reachmd.com/programs/cme/nonsteroidal-mra-sglt2i-in-people-with-ckd-t2d-current-evidence-and-rationale-for-combination-therapy/29909/Explore the potential of combining a nonsteroidal MRA & SGLT2i in patients with CKD & T2D with expert insights on data from the CONFIDENCE trial.Mechanisms of Pressure Relief in Glaucoma: Pharmacologic & Surgical Advances for Refractory POAG or Non-Adherence
https://reachmd.com/programs/cme/mechanisms-pressure-relief-glaucoma-pharmacologic-surgical-advances-refractory-poag-or-non-adherence/9931/Glaucoma experts will discuss new pharmacologic and surgical advances in primary open-angle glaucoma (POAG) and ocular hypertension.New Frontiers in the Treatment of DMD Across the Age Spectrum
https://reachmd.com/programs/cme/new-frontiers-in-the-treatment-of-dmd-across-the-age-spectrum/32740/Explore the latest treatment options, age-specific management strategies, and clinical trial data for patients with Duchenne muscular dystrophy (DMD). Through expert-led discussions and real-world patient cases, you’ll gain practical insights to help you confidently navigate today’s ever-evolving tr